Recent studies have shown that TREM2+ macrophages are the main subsets of tumor-associated macrophages (TAMs) that mediate immune suppression and resistance to immunotherapy (45, 46), confirming that targeting immune checkpoint molecules on T cells is not the only way to attenuate T cell dysfunction. Here, TREM2 is linked to neoplasm.